Bioqube Ventures
Overview
Bioqube Ventures is a Europe-rooted venture capital firm with a global reach that is focused on investing in companies developing therapeutics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bicara Therapeutics | Dec 2023 | Series C | Co-investor |
| Enhanced Genomics | Sep 2025 | Series A | Co-investor |
| SynOx Therapeutics | Oct 2024 | Series B Extension | Co-investor |
| Primmune Therapeutics | Jan 2026 | Series B | Co-investor |
| Anavo Therapeutics | May 2023 | Seed | Co-investor |
For institutional investors. Book with your work email.
Key People
Joris Vanderlocht
Partner and CSO
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bioqube Ventures based?
Bioqube Ventures is headquartered in Brussels, Belgium.
When was Bioqube Ventures founded?
Bioqube Ventures was founded in 2015.
How many portfolio companies does Bioqube Ventures have?
Bioqube Ventures has 11 portfolio companies in Caplight's dataset.
What are some companies in Bioqube Ventures's portfolio?
Portfolio companies visible on Caplight include Bicara Therapeutics, Enhanced Genomics, SynOx Therapeutics, Primmune Therapeutics, Anavo Therapeutics.
What was Bioqube Ventures's most recent investment shown here?
Bioqube Ventures's most recent investment in this portfolio sample was in Primmune Therapeutics in 2026.
What sectors does Bioqube Ventures focus on?
Bioqube Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Bioqube Ventures focus on?
Bioqube Ventures typically invests at the Early stage.
What is Bioqube Ventures's AUM?
Bioqube Ventures's assets under management are estimated between $70.8M and $118.0M.